mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variantsAurélien Sokal, Matthieu Mahévas, Imane Azzaoui et al.|Immunity|2021Cited by 143
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Marion Noret, Nathan Peiffer‐Smadja et al.|Clinical Microbiology and Infection|2021Cited by 107
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variantAurélien Sokal, Matthieu Mahévas, Matteo Broketa et al.|Immunity|2022Cited by 52
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individualsAurélien Sokal, Pascal Chappert, Giovanna Barba–Spaeth et al.|Immunity|2023Cited by 32
Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trialFlorence Ader, Marion Noret, Nathan Peiffer‐Smadja et al.|medRxiv|2021Cited by 15